MYGN FY 2019 Earnings — Myriad Genetics, Inc. Revenue & Financial Results | Market Cap Arena

MYGNMyriad Genetics, Inc.

$454M

FY 2019 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$639M-25.0% YoY

Gross Profit

$453M70.9% margin

Operating Income

-$232M-36.3% margin

Net Income

-$200M-31.2% margin

EPS (Diluted)

$-2.69

Cash Flow

Operating Cash Flow

$61M

Free Cash Flow

$51M

Stock-Based Comp.

$25M

Balance Sheet

Total Assets

$1.6B

Total Liabilities

$474M

Stockholders' Equity

$1.1B

Cash & Equivalents

$93M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$639M	$851M	-25.0%
Gross Profit	$453M	$650M	-30.4%
Operating Income	-$232M	$8M	-3148.7%
Net Income	-$200M	$5M	-4437.0%